Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Schiller Website

John T. Schiller, Ph.D.

Selected Publications

1)  Çuburu N, Graham BS, Buck CB, Kines RC, Pang YY, Day PM, Lowy DR, Schiller JT.
Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.
J. Clin. Invest. 122: 4606-20, 2012.
2)  Schiller JT, Lowy DR.
Understanding and learning from the success of prophylactic human papillomavirus vaccines.
Nat. Rev. Microbiol. 10: 681-92, 2012.
3)  Day PM, Kines RC, Thompson CD, Jagu S, Roden RB, Lowy DR, Schiller JT.
In vivo mechanisms of vaccine-induced protection against HPV infection.
Cell Host Microbe. 8: 260-70, 2010.
4)  Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, Choyke PL, Lowy DR, Schiller JT.
Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan.
Nat. Med. 13: 857-61, 2007.
5)  Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT.
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
Proc. Natl. Acad. Sci. U.S.A. 89: 12180-4, 1992.
6)  Robbins HA, Kemp TJ, Porras C, Rodriguez AC, Schiffman M, Wacholder S, Gonzalez P, Schiller J, Lowy D, Poncelet S, Esser M, Matys K, Hildesheim A, Pinto LA, Herrero R, Safaeian M.
Comparison of antibody responses to human papillomavirus vaccination as measured by three assays.
Front Oncol. 3: 328, 2014.
7)  Robbins HA, Li Y, Porras C, Pawlita M, Ghosh A, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Gonzalez P, Schiller J, Lowy D, Esser M, Matys K, Quint W, van Doorn LJ, Herrero R, Pinto LA, Hildesheim A, Waterboer T, Safaeian M.
Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus.
BMC Infect. Dis. 14: 120, 2014.
8)  Kalnin K, Tibbitts T, Yan Y, Stegalkina S, Shen L, Costa V, Sabharwal R, Anderson SF, Day PM, Christensen N, Schiller J, Jagu S, Roden RB, Almond J, Kleanthous H.
Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes.
Vaccine. [Epub ahead of print], 2014.
9)  Schiller JT, Lowy DR.
Virus infection and human cancer: an overview.
Recent Results Cancer Res. 193: 1-10, 2014.
10)  Handisurya A, Day PM, Thompson CD, Buck CB, Pang YY, Lowy DR, Schiller JT.
Characterization of Mus musculus papillomavirus 1 infection in situ reveals an unusual pattern of late gene expression and capsid protein localization.
J. Virol. 87: 13214-25, 2013.
Click Here to View Expanded Bibliography.

This page was last updated on 6/17/2014.